MSA
ACOR

Mason Street Advisors’s Acorda Therapeutics ACOR Stock Holding History

Mason Street Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-139
Closed -$16K – 1524
2020
Q1 		$16K Hold
139
– – ﹤0.01% 1533
2019
Q4 		$34K Buy
139
+3
+2% +$757 ﹤0.01% 1518
2019
Q3 		$47K Buy
136
+25
+23% +$13.6K ﹤0.01% 1508
2019
Q2 		$102K Buy
111
+5
+5% +$6.14K ﹤0.01% 1466
2019
Q1 		$169K Buy
106
+4
+4% +$7.21K ﹤0.01% 1440
2018
Q4 		$191K Buy
102
+5
+5% +$10.9K ﹤0.01% 1337
2018
Q3 		$229K Sell
97
-16
-14% -$49.5K ﹤0.01% 1343
2018
Q2 		$390K Buy
113
+5
+5% +$15.3K 0.01% 1170
2018
Q1 		$308K Buy
108
+7
+7% +$21K 0.01% 1206
2017
Q4 		$261K Buy
101
+3
+3% +$8.53K 0.01% 1251
2017
Q3 		$279K Buy
98
+2
+2% +$5.27K 0.01% 1218
2017
Q2 		$227K Buy
96
+6
+7% +$11.9K 0.01% 1260
2017
Q1 		$228K Buy
90
+6
+7% +$17.3K 0.01% 1230
2016
Q4 		$189K Buy
84
+5
+6% +$11.9K 0.01% 1274
2016
Q3 		$198K Buy
79
+4
+5% +$11.9K 0.01% 1206
2016
Q2 		$230K Buy
75
+7
+10% +$22.8K 0.01% 1129
2016
Q1 		$215K Buy
68
+10
+17% +$41.5K 0.01% 1118
2015
Q4 		$298K Buy
58
+5
+9% +$21.9K 0.01% 988
2015
Q3 		$167K Buy
53
+4
+8% +$15.5K 0.01% 1136
2015
Q2 		$197K Buy
49
+2
+4% +$7.73K 0.01% 1090
2015
Q1 		$188K Sell
47
-929
-95% -$4.25M 0.01% 1105
2014
Q4 		$4.79M Buy
976
+268
+38% +$1.15M 0.03% 555
2014
Q3 		$2.88M Sell
708
-1
-0.1% -$3.75K 0.02% 773
2014
Q2 		$2.87M Buy
709
+2
+0.3% +$8.15K 0.02% 778
2014
Q1 		$3.22M Sell
707
-13
-2% -$52.6K 0.03% 717
2013
Q4 		$2.52M Buy
720
+5
+0.7% +$19.5K 0.02% 823
2013
Q3 		$2.94M Buy
715
+668
+1,421% +$2.88M 0.03% 527
2013
Q2 		$185K Buy
+47
New +$194K ﹤0.01% 1243

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mason Street Advisors's ACOR Position: Q2 2020 in Review

Mason Street Advisors sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 139 shares — an estimated $16K sold.

Mason Street Advisors first reported a position in ACOR in Q2 2013 and held it in 28 quarters. The position peaked at $4.79M in Q4 2014. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • Mason Street Advisors reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Mason Street Advisors sold 139 Acorda Therapeutics shares in Q2 2020, an estimated $16K.
  • Mason Street Advisors first reported a position in Acorda Therapeutics in Q2 2013 and held it in 28 quarters.
  • Mason Street Advisors's Acorda Therapeutics position peaked at $4.79M in Q4 2014.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Mason Street Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.